“A Message from Kagoshima for Companies and People in a Borderless World.”

Ken Takanashi, Executive Vice President, Shin Nippon Biomedical Laboratories, Ltd.

Shin Nippon Biomedical Laboratories, Ltd. (SNBL) is a nonclinical contract research organization (CRO) that was founded in Kagoshima, Japan, in 1957. The company employs over 2000 people and is currently trading in Tokyo Stock Exchange Prime Market. SNBL provides services and solutions for drug discovery and development for pharmaceutical compa- nies, biotech ventures, universities, and research institutions both in Japan and overseas. In addition, SNBL is very active in the local community as well as in the area of environmental conservation. For further information, visit https://www.snbl.co.jp.

Скачать видео